The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets

British Journal of Pharmacology

Volumn 160, Issue 4, 2010, Pages 821-832

  Penela, Petronila ^a   Murga, Cristina ^a   Ribas, Catalina ^a   Lafarga, Vanesa ^a   Mayor Jr , Federico ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Arrestin; Cardiovascular; Cell cycle; GPCR; GRK2; Migration

Indexed keywords

ACTIN; ADENOVIRUS VECTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOXORUBICIN; EZRIN; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PARVOVIRUS VECTOR; PAXILLIN; PHOSDUCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; RANTES; RETINA S ANTIGEN; RHODOPSIN KINASE; STROMAL CELL DERIVED FACTOR 1; SYNUCLEIN; TOLL LIKE RECEPTOR 4; TUBULIN; UNINDEXED DRUG; ENZYME INHIBITOR;

CARDIOVASCULAR DISEASE; CELL CYCLE PROGRESSION; CELL MIGRATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SUBSTRATE; EPITHELIUM CELL; HEART FAILURE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; LIVER CELL CARCINOMA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR SYSTEM; CELL CYCLE; CELL MOTION; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; ENZYME SPECIFICITY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR SYSTEM; CELL CYCLE; CELL MOVEMENT; DRUG DESIGN; ENZYME INHIBITORS; G-PROTEIN-COUPLED RECEPTOR KINASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 77952840083     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00727.x     Document Type: Review

References (80)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Anis Y, Leshem O, Reuveni H, Wexler I, Ben Sasson R, Yahalom B et al 2004). Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia 47 : 1232 1244.
3. Aziziyeh AI, Li TT, Pape C, Pampillo M, Chidiac P, Possmayer F et al 2009). Dual regulation of lysophosphatidic acid (LPA1) receptor signalling by Ral and GRK. Cell Signal 21 : 1207 1217.
4. Bliziotes M, Gunness M, Zhang X, Nissenson R, Wiren K (2000). Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. Bone 27 : 367 373.
5. Brockbank EC, Bridges J, Marshall CJ, Sahai E (2005). Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo. Br J Cancer 92 : 102 112.
6. Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA et al 2004). Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science 306 : 2257 2260.
7. Chen Y, Long H, Wu Z, Jiang X, Ma L (2008). EGF Transregulates Opioid Receptors through EGFR-mediated GRK2 Phosphorylation and Activation. Mol Biol Cell 19 : 2973 2983.
8. Cipolletta E, Campanile A, Santulli G, Sanzari E, Leosco D, Campiglia P et al 2009). The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. Cardiovasc Res 84 : 407 415.
9. Cohn HI, Harris DM, Pesant S, Pfeiffer M, Zhou RH, Koch WJ et al 2008). Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances alpha1D-adrenergic receptor constriction. Am J Physiol 295 : H1695 H1704.
10. Cohn HI, Xi Y, Pesant S, Harris DM, Hyslop T, Falkner B et al 2009). G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension 54 : 71 76.
11. DeFea KA (2007). Stop that cell! Beta-arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu Rev Physiol 69 : 535 560.
12. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007). Beta-arrestins and cell signaling. Annu Rev Physiol 69 : 483 510.
13. Dinudom A, Fotia AB, Lefkowitz RJ, Young JA, Kumar S, Cook DI (2004). The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na+ channels. Proc Natl Acad Sci U S A 101 : 11886 11890.
14. Dorn GW, 2nd. (2009a). GRK mythology: G-protein receptor kinases in cardiovascular disease. J Mol Med 87 : 455 463.
15. Dorn GW, 2nd. (2009b). Novel pharmacotherapies to abrogate postinfarction ventricular remodeling. Nat Rev Cardiol 6 : 283 291.
16. Dorsam RT, Gutkind JS (2007). G-protein-coupled receptors and cancer. Nat Rev Cancer 7 : 79 94.
17. Eckhart AD, Ozaki T, Tevaearai H, Rockman HA, Koch WJ (2002). Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 61 : 749 758.
18. Elorza A, Penela P, Sarnago S, Mayor F, Jr. (2003). MAPK-dependent degradation of G protein-coupled receptor kinase 2. J Biol Chem 278 : 29164 29173.
19. Elorza A, Sarnago S, Mayor F, Jr. (2000). Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol Pharmacol 57 : 778 783.
20. Fan G, Ballou LM, Lin RZ (2003). Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq. J Biol Chem 278 : 52432 52436.
21. Ferguson SS (2007). Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol Sci 28 : 173 179.
22. Gros R, Benovic JL, Tan CM, Feldman RD (1997). G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 99 : 93.
23. Gros R, Chorazyczewski J, Meek MD, Benovic JL, Ferguson SS, Feldman RD (2000). G-protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 35 : 38 42.
24. Guo J, Chen H, Ho J, Mancini J, Sontag T, Laporte SA et al 2009). TGFbeta-induced GRK2 expression attenuates AngII-regulated Vascular Smooth Muscle Cell proliferation and migration. Cell Signal 21 : 899 905.
25. Hildreth KL, Wu JH, Barak LS, Exum ST, Kim LK, Peppel K et al 2004). Phosphorylation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-2 reduces receptor signaling and interaction with the Na(+)/H(+) exchanger regulatory factor. J Biol Chem 279 : 41775 41782.
26. Ho J, Cocolakis E, Dumas VM, Posner BI, Laporte SA, Lebrun JJ (2005). The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. Embo J 24 : 3247 3258.
27. Hoefen RJ, Berk BC (2006). The multifunctional GIT family of proteins. J Cell Sci 119 : 1469 1475.
28. Hupfeld CJ, Olefsky JM (2007). Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins. Annu Rev Physiol 69 : 561 577.
29. Iaccarino G, Barbato E, Cipolletta E, De Amicis V, Margulies KB, Leosco D et al 2005). Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 26 : 1752 1758.
30. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK et al 1996). Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A 93 : 12974 12979.
31. Jiang X, Yang P, Ma L (2009). Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development. Proc Natl Acad Sci U S A 106 : 10183 10188.
32. Jimenez-Sainz MC, Murga C, Kavelaars A, Jurado-Pueyo M, Krakstad BF, Heijnen CJ et al 2006). G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from g protein subunits. Mol Biol Cell 17 : 25 31.
33. Koch WJ, Lefkowitz RJ, Milano CA, Akhter SA, Rockman HA (1998). Myocardial overexpression of adrenergic receptors and receptor kinases. Adv Pharmacol 42 : 502 506.
34. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC (2005). A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 11 : 952 958.
35. Lodowski DT, Barnhill JF, Pitcher JA, Capel WD, Lefkowitz RJ, Tesmer JJ (2003). Purification, crystallization and preliminary X-ray diffraction studies of a complex between G protein-coupled receptor kinase 2 and Gbeta1gamma2. Acta Crystallogr D Biol Crystallogr 59 : 936 939.
36. Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ (2007). Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13 : 315 323.
37. Matkovich SJ, Diwan A, Klanke JL, Hammer DJ, Marreez Y, Odley AM et al 2006). Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling. Circ Res 99 : 996 1003.
38. Mayer G, Wulffen B, Huber C, Brockmann J, Flicke B, Neumann L et al 2008). An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. RNA 14 : 524 534.
39. Meloni AR, Fralish GB, Kelly P, Salahpour A, Chen JK, Wechsler-Reya RJ et al 2006). Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol Cell Biol 26 : 7550 7560.
40. Metaye T, Gibelin H, Perdrisot R, Kraimps JL (2005). Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal 17 : 917 928.
41. Metaye T, Levillain P, Kraimps JL, Perdrisot R (2008). Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. J Endocrinol 198 : 101 110.
42. Metaye T, Menet E, Guilhot J, Kraimps JL (2002). Expression and activity of G protein-coupled receptor kinases in differenciated thyroid carcinoma. J Clin Endocrinol Metab 87 : 3279 3286.
43. Milstien S, Spiegel S (2006). Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell 9 : 148 150.
44. Molnar C, Holguin H, Mayor F, Jr., Ruiz-Gomez A, de Celis JF (2007). The G protein-coupled receptor regulatory kinase GPRK2 participates in Hedgehog signaling in Drosophila. Proc Natl Acad Sci U S A 104 : 7963 7968.
45. Moore CA, Milano SK, Benovic JL (2007). Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69 : 451 482.
46. Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, Rockman HA (2002). Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 158 : 563 575.
47. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J et al 2007). Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117 : 2445 2458.
48. Patial S, Luo J, Porter KJ, Benovic JL, Parameswaran N (2009). G-protein coupled receptor kinases mediate TNFalpha-induced NFkappaB signaling via direct interaction with and phosphorylation of IkappaBalpha. Biochem J 425 : 169 178.
49. Penela P, Ruiz-Gomez A, Castano JG, Mayor F, Jr. (1998). Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway. J Biol Chem 273 : 35238 35244. (Pubitemid 29028230)
50. Penela P, Elorza A, Sarnago S, Mayor F, Jr. (2001). Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. Embo J 20 : 5129 5138.
51. Penela P, Ribas C, Mayor F, Jr. (2003). Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal 15 : 973 981.
52. Penela P, Murga C, Ribas C, Tutor AS, Peregrin S, Mayor F, Jr. (2006). Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc Res 69 : 46 56.
53. Penela P, Ribas C, Aymerich I, Eijkelkamp N, Barreiro O, Heijnen CJ et al 2008). G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. Embo J 27 : 1206 1218. (Pubitemid 351574750)
54. Penela P, Ribas C, Aymerich I, Mayor F, Jr. (2009). New roles of G protein-coupled receptor kinase 2 (GRK2) in cell migration. Cell Adh Migr 3 : 19 23.
55. Penela P, Rivas V, Salcedo A, Mayor F Jr. (2010). G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc Natl Acad Sci U S A 107 : 1118 1123.
56. Peppel K, Jacobson A, Huang X, Murray JP, Oppermann M, Freedman NJ (2000). Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors. Circulation 102 : 793 799.
57. Peregrin S, Jurado-Pueyo M, Campos PM, Sanz-Moreno V, Ruiz-Gomez A, Crespo P et al 2006). Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Curr Biol 16 : 2042 2047.
58. Pitcher JA, Tesmer JJ, Freeman JL, Capel WD, Stone WC, Lefkowitz RJ (1999). Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem 274 : 34531 34534.
59. Premont RT, Claing A, Vitale N, Freeman JL, Pitcher JA, Patton W et al 1998). β2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A 95 : 14082 14087.
60. Premont RT, Gainetdinov RR (2007). Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69 : 511 534.
61. Prowatke I, Devens F, Benner A, Grone EF, Mertens D, Grone HJ et al 2007). Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. Br J Cancer 96 : 82 88.
62. Raake PW, Vinge LE, Gao E, Boucher M, Rengo G, Chen X et al 2008). G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res 103 : 413 422.
63. Ramos-Ruiz R, Penela P, Penn RB, Mayor F, Jr. (2000). Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. Circulation 101 : 2083 2089.
64. Reiter E, Lefkowitz RJ (2006). GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17 : 159 165.
65. Rengo G, Lymperopoulos A, Zincarelli C, Donniacuo M, Soltys S, Rabinowitz JE et al 2009). Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 119 : 89 98.
66. Ribas C, Penela P, Murga C, Salcedo A, Garcia-Hoz C, Jurado-Pueyo M et al 2007). The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768 : 913 922.
67. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G et al 2003). Cell migration: integrating signals from front to back. Science 302 : 1704 1709.
68. Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J et al 1998). Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A 95 : 7000 7005.
69. Salcedo A, Mayor F, Jr., Penela P (2006). Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. Embo J 25 : 4752 4762.
70. Sarnago S, Elorza A, Mayor F, Jr. (1999). Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase. J Biol Chem 274 : 34411 34416.
71. Tarrant TK, Rampersad RR, Esserman D, Rothlein LR, Liu P, Premont RT et al 2008). Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). Clin Immunol 129 : 115 122.
72. Tesmer VM, Kawano T, Shankaranarayanan A, Kozasa T, Tesmer JJ (2005). Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 310 : 1686 1690.
73. Theilade J, Strom C, Christiansen T, Haunso S, Sheikh SP (2003). Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat. Basic Res Cardiol 98 : 97 103.
74. Vroon A, Heijnen CJ, Kavelaars A (2006). GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 80 : 1214 1221.
75. Vroon A, Heijnen CJ, Lombardi MS, Cobelens PM, Mayor F, Jr., Caron MG et al 2004). Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukoc Biol 75 : 901 909.
76. Vroon A, Kavelaars A, Limmroth V, Lombardi MS, Goebel MU, Van Dam AM et al 2005). G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 174 : 4400 4406.
77. Wan KF, Sambi BS, Tate R, Waters C, Pyne NG (2003). The inhibitory γ subunit of the type 6 retinal cGMP phosphodiesterase functions to link c-Src and G-protein-coupled receptor kinase 2 in a signaling unit that regulates p42/p44 mitogen-activated protein kinase by epidermal growth factor. J Biol Chem 278 : 18658 18663.
78. Wang L, Gesty-Palmer D, Fields TA, Spurney RF (2009). Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2). Mol Endocrinol 23 : 1455 1465.
79. Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG et al 2007). Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129 : 511 522.
80. Winstel R, Ihlenfeldt HG, Jung G, Krasel C, Lohse MJ (2005). Peptide inhibitors of G protein-coupled receptor kinases. Biochem Pharmacol 70 : 1001 1008.